Abstract
Objective: The purpose of our study is to review the literature on healthcare disparities in PD care among African-American patients in the US.
Background: Parkinson’s disease (PD) is among the most prevalent neurodegenerative disorders and poses a high economic burden on the healthcare system. Although no cure is available, patients can have many productive years when receiving state-of-the-art treatment. Previous studies have shown considerable disparities in PD care based on racial and socioeconomic status, specifically in the African-American community.
Design/Methods: Publications from 1996–2016 were reviewed, using the following databases: PubMed, Medline, Scopus, Embase, and Ovid.
Results: We identified 15 articles meeting our criteria. Studies showed evidence of significant disparities in time of diagnosis and treatment received. One study found African-American patients four times less likely to be started on treatment for PD than Caucasians over the same follow-up period. A study performed in the VA system showed an average seven-year delay in receiving a diagnosis of PD in the African-American population. Review of a large hospital database revealed discrepancies in access to deep brain stimulation surgery, with 85.9% of patients being Caucasian and only 0.6% African-American. Disparities in PD care may result from differences in insurance status, access to medical care, cultural biases and healthcare literacy.
Conclusions: Optimal management of PD requires timely diagnosis, treatment initiation and regular follow- up to address motor and non-motor symptoms. Disparities exist on several levels for African-American patients and efforts are urgently needed to address these. Creating public awareness of racial disparities in PD care is a first step to initiate changes. We developed a local initiative in Kentucky (“UofL Moves!”) to provide PD education to underserved patients and families, spread awareness and knowledge about racial disparities to healthcare providers and provide resources for PD care for everyone.
Disclosure: Dr. Naik has nothing to disclose. Dr. LaFaver has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Teva, GLG .
Disputes & Debates: Rapid online correspondence
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.